Burak Derkus | Cellular Neuroscience | Best Researcher Award

Prof. Burak Derkus | Cellular Neuroscience | Best Researcher Award

Prof. Burak Derkus, Ankara University, Turkey.

Prof. Burak Derkus has distinguished himself as a pioneering academic and researcher at Ankara University, Turkey, where he has played a vital role in shaping the future of biomedical engineering. His work spans across key disciplines such as biosensors, nanobiotechnology, and lab-on-a-chip technologies. By merging biology with cutting-edge engineering, he has developed innovative solutions aimed at improving diagnostic efficiency and accessibility. His career reflects a balance between scientific discovery, practical application, and educational leadership.

Profile

Google Scholar

šŸŽ“ Early Academic Pursuits

From the heart of Turkey, Prof. Burak Derkus began his journey into the world of science and discovery with an unwavering curiosity and dedication. His early academic path was marked by a strong foundation in biomedical sciences, which he cultivated during his undergraduate and postgraduate studies. Prof. Derkus demonstrated exceptional aptitude in analytical thinking and laboratory precision, laying the groundwork for a promising academic future. His formative years were spent exploring the intersections of biology, materials science, and engineering, which later became the pillars of his specialized research focus.

🧪 Professional Endeavors

Prof. Derkus established himself as a dynamic figure in academia through his ongoing association with Ankara University, one of Turkey’s leading research institutions. Here, he contributed not only as a scholar but also as a mentor, actively participating in the development of innovative curriculum modules and engaging students in high-impact research. His professional path is characterized by his interdisciplinary approach, blending principles of nanotechnology, biomedical engineering, and microfabrication to tackle complex challenges in healthcare and diagnostics.

šŸ”¬ Contributions and Research Focus

Renowned for his pioneering work in lab-on-a-chip systems, biosensors, and nanobiotechnology, Prof. Derkus has carved out a unique niche in biomedical microdevices. His research focuses on developing miniaturized platforms that can detect diseases with higher sensitivity, speed, and accuracy. By integrating biomaterials with microfluidic technologies, he aims to revolutionize early disease diagnosis and personalized medicine. His published works are rich with innovation, often bridging the gap between engineering and clinical applications.

šŸ… Accolades and Recognition

Over the years, Prof. Derkus has earned numerous accolades that reflect his scientific excellence and leadership. His publications in high-impact journals, along with international conference presentations, have positioned him as a thought leader in the biomedical engineering community. He has been invited to serve on editorial boards and scientific committees, further endorsing his reputation as a respected academic figure. These honors underscore his persistent efforts in advancing applied sciences and improving public health through technological innovation.

šŸŒ Impact and Influence

Prof. Derkus’s influence extends beyond Turkey, resonating across international scientific circles. His research projects have fostered collaborations with institutions across Europe and Asia, facilitating knowledge exchange and cross-border innovation. By mentoring graduate students and young researchers, he continues to inspire a new generation of scientists. His contributions to the development of cost-effective, portable diagnostic tools hold immense potential for global health, particularly in under-resourced communities.

šŸ“š Legacy and Future Contributions

Prof. Derkus is not just a researcher but a visionary thinker. His legacy is being built upon the transformative technologies he develops, aimed at addressing the future needs of society. His ongoing work promises to enhance biomedical diagnostics, therapeutic monitoring, and point-of-care testing. Looking ahead, he is poised to lead larger interdisciplinary collaborations, potentially contributing to the design of smart diagnostic devices powered by artificial intelligence and integrated sensors.

Publication

  • Title: Supramolecular self-assembly to control structural and biological properties of multicomponent hydrogels
    Authors: BO Okesola, Y Wu, B Derkus, S Gani, D Wu, D Knani, DK Smith, …
    Year: 2019

 

  • Title: Fabrication of human hair keratin/jellyfish collagen/eggshell-derived hydroxyapatite osteoinductive biocomposite scaffolds for bone tissue engineering: From waste to …
    Authors: YE Arslan, TS Arslan, B Derkus, E Emregul, KC Emregul
    Year: 2017

 

  • Title: Applying the miniaturization technologies for biosensor design
    Authors: B Derkus
    Year: 2016

 

  • Title: Myelin basic protein immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy
    Authors: B Derkus, E Emregul, C Yucesan, KC Emregul
    Year: 2013

 

  • Title: Simultaneous quantification of Myelin Basic Protein and Tau proteins in cerebrospinal fluid and serum of Multiple Sclerosis patients using nanoimmunosensor
    Authors: B Derkus, PA Bozkurt, M Tulu, KC Emregul, C Yucesan, E Emregul
    Year: 2017

 

  • Title: Growth‐Factor Free Multicomponent Nanocomposite Hydrogels That Stimulate Bone Formation
    Authors: B Okesola, S Ni, B Derkus, C Galeano, A Hasan, Y Wu, J Ramis, L Buttery, …
    Year: 2020

 

  • Title: Untargeted multi-omic analysis of colorectal cancer-specific exosomes reveals joint pathways of colorectal cancer in both clinical samples and cell culture
    Authors: CC Eylem, M Yilmaz, B Derkus, E Nemutlu, CB Camci, E Yilmaz, …
    Year: 2020

 

  • Title: Multicomponent hydrogels for the formation of vascularized bone-like constructs in vitro
    Authors: B Derkus, BO Okesola, DW Barrett, M D’Este, TT Chowdhury, D Eglin, …
    Year: 2020

 

 

🧭 Conclusion

Prof. Derkus’s journey is a testament to the power of interdisciplinary research and its potential to drive meaningful change in global healthcare. His contributions have not only advanced scientific knowledge but also inspired collaborative innovation on an international scale. With a forward-looking mindset and a deep commitment to societal benefit, he continues to influence the field through research, mentorship, and visionary thinking. As science and medicine evolve, Prof. Burak Derkus remains a guiding force, building a legacy rooted in healing, discovery, and human impact.

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

šŸŽ“ Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

šŸ‘Øā€šŸŽ“ Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

šŸ† Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

šŸ° Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

āš›ļø Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.